United States· US:42227-081_421ea216-278f-4ca8-ae5d-5dafe85658a0

Cinryze

A medicinal product containing human c1-esterase inhibitor, registered in United States by Takeda Pharmaceuticals America, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCinryzeATC—REGISTER NO.US:42227-081_421ea216…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
HUMAN C1-ESTERASE INHIBITOR
Manufacturer
Takeda Pharmaceuticals America, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    4222708101
    5 mL in 1 VIAL, SINGLE-USE (42227-081-01)
  • ndc11
    42227-081-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Human c1-esterase inhibitor in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human c1-esterase inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Berinert
  • Belgium · Berinert
  • Bulgaria · Беринерт
  • Cyprus · Berinert
  • Czechia · Berinert
  • Germany · Berinert
  • Denmark · Berinert
  • Estonia · Berinert Iv, Berinert Sc
  • Spain · Berinert
  • Finland · Berinert
  • France · Berinert
  • United Kingdom (Northern Ireland) · Berinert
  • Greece · Berinert
  • Croatia · Berinert
  • Hungary · Berinert
  • Ireland · Berinert
  • Iceland · Berinert, Cinryze
  • Italy · Berinert
  • Liechtenstein · Cinryze
  • Lithuania · Human C1-Esterase Inhibitor Csl Behring
  • Luxembourg · Berinert
  • Malta · Berinert
  • Netherlands · Berinert
  • Norway · Berinert, Cinryze
  • Poland · Berinert
  • Portugal · Berinert
  • Romania · Berinert
  • Sweden · Berinert
  • Slovenia · Berinert
  • Slovakia · Berinert

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebfbc544-bab8-4048-b53e-a703de2f985d
GET /v1/drugs/ebfbc544-bab8-4048-b53e-a703de2f985d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "500",
  "substance": "HUMAN C1-ESTERASE INHIBITOR",
  "productndc": "42227-081",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "[iU]/5mL",
  "application_number": "BLA125267",
  "marketing_category": "BLA"
}

See everything about human c1-esterase inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.